The ongoing debate at COP28 over the phase out of fossil fuels is impeding efforts to address the severe impacts of climate change.
Victoria Corless
Science enthusiast, writer and editor for Advanced Science News.
After completing a Ph.D. in chemistry, Victoria worked as freelance science communicator and medical writer before joining ASN.
Getting to the bottom of chronic nerve pain
New findings point to the crucial role that mRNA modifications play in how the body regulates pain-related molecules.
CRISPR gene therapy for sickle cell disease and β-thalassemia gets UK approval
In a world first, UK authorities grant regulatory approval for a CRISPR gene therapy targeting sickle cell disease and β-thalassemia.
How education can help the “right to repair” movement
Through awareness and education, individuals may become more conscious of their future spending choices, ultimately contributing to the success of the right to repair movement.
Tackling microplastics and water pollution with magnetic “rust”
Magnetic iron nanoparticles shown to eliminate persistent water pollution, such as microplastics and oils.
Scientists harvest electricity from the movement of molecules
A new frontier in clean energy may be on the horizon with nanoscale generators that capture electricity from molecules.
First ever diagnostic test for chronic fatigue syndrome sparks hope
An innovative blood test designed to identify chronic fatigue syndrome, and potentially applicable to long COVID and Lyme disease, boasts 91% accuracy.
First animal model to show the effects of gender-affirming hormone therapy on fertility
Scientists investigate the impact of hormone therapy on the fertility of trans individuals, shedding light on unknown aspects of reproductive health.
Turning plastic waste into low-cost hydrogen fuels
A flash heating technique breaks down plastic waste and converts it to pure hydrogen and graphene with significantly less emissions and at a low cost.
No more needles, an oral insulin medication could be on the horizon
A self-assembling helix formed from nateglinide, a complementary diabetes treatment, provides a protective coating that could open the door to an oral insulin medication.